nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—ovarian cancer	0.339	1	CbGaD
Promethazine—ABCB1—Topotecan—ovarian cancer	0.0403	0.21	CbGbCtD
Promethazine—ABCB1—Vinorelbine—ovarian cancer	0.0284	0.148	CbGbCtD
Promethazine—CYP2D6—Vinorelbine—ovarian cancer	0.0267	0.139	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—ovarian cancer	0.0209	0.109	CbGbCtD
Promethazine—CYP2C9—Paclitaxel—ovarian cancer	0.0205	0.107	CbGbCtD
Promethazine—ABCB1—Paclitaxel—ovarian cancer	0.0199	0.104	CbGbCtD
Promethazine—ABCB1—Docetaxel—ovarian cancer	0.0144	0.075	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—ovarian cancer	0.0122	0.109	CbGeAlD
Promethazine—ABCB1—Doxorubicin—ovarian cancer	0.0107	0.0559	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—ovarian cancer	0.0101	0.0527	CbGbCtD
Promethazine—CALM2—oviduct—ovarian cancer	0.00566	0.0507	CbGeAlD
Promethazine—HTR2A—vein—ovarian cancer	0.00558	0.0499	CbGeAlD
Promethazine—HRH4—bone marrow—ovarian cancer	0.00454	0.0406	CbGeAlD
Promethazine—CHRM5—epithelium—ovarian cancer	0.00259	0.0232	CbGeAlD
Promethazine—CALM3—myometrium—ovarian cancer	0.0023	0.0206	CbGeAlD
Promethazine—CHRM4—testis—ovarian cancer	0.00199	0.0178	CbGeAlD
Promethazine—CALM2—myometrium—ovarian cancer	0.00181	0.0162	CbGeAlD
Promethazine—CALM1—myometrium—ovarian cancer	0.0018	0.0161	CbGeAlD
Promethazine—CALM3—uterine cervix—ovarian cancer	0.00179	0.0161	CbGeAlD
Promethazine—CALM2—embryo—ovarian cancer	0.00174	0.0156	CbGeAlD
Promethazine—CALM1—embryo—ovarian cancer	0.00173	0.0155	CbGeAlD
Promethazine—CALM3—decidua—ovarian cancer	0.00171	0.0153	CbGeAlD
Promethazine—CALM3—endometrium—ovarian cancer	0.00162	0.0145	CbGeAlD
Promethazine—CALM3—uterus—ovarian cancer	0.00149	0.0134	CbGeAlD
Promethazine—CALM2—epithelium—ovarian cancer	0.00142	0.0127	CbGeAlD
Promethazine—CALM1—epithelium—ovarian cancer	0.00141	0.0127	CbGeAlD
Promethazine—CALM2—uterine cervix—ovarian cancer	0.00141	0.0126	CbGeAlD
Promethazine—CALM1—uterine cervix—ovarian cancer	0.0014	0.0126	CbGeAlD
Promethazine—CALM2—decidua—ovarian cancer	0.00134	0.012	CbGeAlD
Promethazine—CALM1—decidua—ovarian cancer	0.00134	0.012	CbGeAlD
Promethazine—ADRA1A—epithelium—ovarian cancer	0.00133	0.0119	CbGeAlD
Promethazine—HRH1—myometrium—ovarian cancer	0.00131	0.0118	CbGeAlD
Promethazine—CALM2—endometrium—ovarian cancer	0.00127	0.0114	CbGeAlD
Promethazine—CALM3—bone marrow—ovarian cancer	0.00127	0.0114	CbGeAlD
Promethazine—CALM1—endometrium—ovarian cancer	0.00127	0.0114	CbGeAlD
Promethazine—CALM3—female gonad—ovarian cancer	0.00122	0.0109	CbGeAlD
Promethazine—CALM3—vagina—ovarian cancer	0.00121	0.0109	CbGeAlD
Promethazine—CHRM1—female reproductive system—ovarian cancer	0.0012	0.0108	CbGeAlD
Promethazine—CALM2—gonad—ovarian cancer	0.00118	0.0106	CbGeAlD
Promethazine—CALM1—gonad—ovarian cancer	0.00118	0.0105	CbGeAlD
Promethazine—CALM2—uterus—ovarian cancer	0.00117	0.0105	CbGeAlD
Promethazine—CALM1—uterus—ovarian cancer	0.00117	0.0105	CbGeAlD
Promethazine—CALM3—testis—ovarian cancer	0.00108	0.00971	CbGeAlD
Promethazine—CHRM3—female reproductive system—ovarian cancer	0.00108	0.00965	CbGeAlD
Promethazine—HTR2A—embryo—ovarian cancer	0.00106	0.00945	CbGeAlD
Promethazine—CALM2—female reproductive system—ovarian cancer	0.00105	0.00945	CbGeAlD
Promethazine—CALM1—female reproductive system—ovarian cancer	0.00105	0.00941	CbGeAlD
Promethazine—HRH1—epithelium—ovarian cancer	0.00103	0.00924	CbGeAlD
Promethazine—HRH1—uterine cervix—ovarian cancer	0.00102	0.00916	CbGeAlD
Promethazine—CALM2—bone marrow—ovarian cancer	0.000996	0.00892	CbGeAlD
Promethazine—CALM1—bone marrow—ovarian cancer	0.000991	0.00888	CbGeAlD
Promethazine—CHRM3—female gonad—ovarian cancer	0.000981	0.00878	CbGeAlD
Promethazine—HRH1—decidua—ovarian cancer	0.000974	0.00872	CbGeAlD
Promethazine—CALM2—female gonad—ovarian cancer	0.00096	0.0086	CbGeAlD
Promethazine—CALM1—female gonad—ovarian cancer	0.000956	0.00856	CbGeAlD
Promethazine—CALM2—vagina—ovarian cancer	0.000954	0.00855	CbGeAlD
Promethazine—CALM1—vagina—ovarian cancer	0.00095	0.00851	CbGeAlD
Promethazine—HRH1—endometrium—ovarian cancer	0.000925	0.00828	CbGeAlD
Promethazine—CYP2B6—gonad—ovarian cancer	0.000878	0.00787	CbGeAlD
Promethazine—CHRM3—testis—ovarian cancer	0.00087	0.00779	CbGeAlD
Promethazine—HTR2A—epithelium—ovarian cancer	0.000861	0.00771	CbGeAlD
Promethazine—CALM2—testis—ovarian cancer	0.000851	0.00763	CbGeAlD
Promethazine—CALM1—testis—ovarian cancer	0.000847	0.00759	CbGeAlD
Promethazine—CALM3—lymph node—ovarian cancer	0.000786	0.00704	CbGeAlD
Promethazine—CYP2B6—female reproductive system—ovarian cancer	0.000784	0.00702	CbGeAlD
Promethazine—DRD2—testis—ovarian cancer	0.000783	0.00701	CbGeAlD
Promethazine—CYP2C9—female reproductive system—ovarian cancer	0.000777	0.00696	CbGeAlD
Promethazine—HRH1—female reproductive system—ovarian cancer	0.000766	0.00686	CbGeAlD
Promethazine—Swelling—Docetaxel—ovarian cancer	0.000746	0.00413	CcSEcCtD
Promethazine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00073	0.00404	CcSEcCtD
Promethazine—Leukopenia—Topotecan—ovarian cancer	0.000728	0.00403	CcSEcCtD
Promethazine—Necrosis—Doxorubicin—ovarian cancer	0.000721	0.00399	CcSEcCtD
Promethazine—ABCB1—myometrium—ovarian cancer	0.000719	0.00644	CbGeAlD
Promethazine—HTR2A—gonad—ovarian cancer	0.000716	0.00642	CbGeAlD
Promethazine—Abscess—Doxorubicin—ovarian cancer	0.000715	0.00396	CcSEcCtD
Promethazine—Arrhythmia—Vinorelbine—ovarian cancer	0.000714	0.00395	CcSEcCtD
Promethazine—Leukopenia—Melphalan—ovarian cancer	0.000712	0.00394	CcSEcCtD
Promethazine—Delirium—Epirubicin—ovarian cancer	0.000711	0.00394	CcSEcCtD
Promethazine—CYP2B6—vagina—ovarian cancer	0.000709	0.00635	CbGeAlD
Promethazine—Extravasation—Epirubicin—ovarian cancer	0.000701	0.00388	CcSEcCtD
Promethazine—HRH1—female gonad—ovarian cancer	0.000697	0.00624	CbGeAlD
Promethazine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.000696	0.00385	CcSEcCtD
Promethazine—Erythema—Vinorelbine—ovarian cancer	0.000695	0.00385	CcSEcCtD
Promethazine—HRH1—vagina—ovarian cancer	0.000693	0.0062	CbGeAlD
Promethazine—ABCB1—embryo—ovarian cancer	0.000692	0.00619	CbGeAlD
Promethazine—Convulsion—Melphalan—ovarian cancer	0.00069	0.00382	CcSEcCtD
Promethazine—Anaphylactic shock—Topotecan—ovarian cancer	0.000663	0.00367	CcSEcCtD
Promethazine—Delirium—Doxorubicin—ovarian cancer	0.000658	0.00364	CcSEcCtD
Promethazine—Dyspepsia—Chlorambucil—ovarian cancer	0.000656	0.00363	CcSEcCtD
Promethazine—Dyskinesia—Epirubicin—ovarian cancer	0.000651	0.0036	CcSEcCtD
Promethazine—Anaphylactic shock—Melphalan—ovarian cancer	0.00065	0.00359	CcSEcCtD
Promethazine—Oedema—Melphalan—ovarian cancer	0.00065	0.00359	CcSEcCtD
Promethazine—Thrombocytopenia—Topotecan—ovarian cancer	0.000649	0.00359	CcSEcCtD
Promethazine—Extravasation—Doxorubicin—ovarian cancer	0.000649	0.00359	CcSEcCtD
Promethazine—Decreased appetite—Chlorambucil—ovarian cancer	0.000648	0.00358	CcSEcCtD
Promethazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000644	0.00356	CcSEcCtD
Promethazine—Fatigue—Chlorambucil—ovarian cancer	0.000642	0.00356	CcSEcCtD
Promethazine—HTR2A—female reproductive system—ovarian cancer	0.00064	0.00573	CbGeAlD
Promethazine—Pain—Chlorambucil—ovarian cancer	0.000637	0.00353	CcSEcCtD
Promethazine—Thrombocytopenia—Melphalan—ovarian cancer	0.000636	0.00352	CcSEcCtD
Promethazine—Tachycardia—Melphalan—ovarian cancer	0.000634	0.00351	CcSEcCtD
Promethazine—CYP2B6—testis—ovarian cancer	0.000633	0.00567	CbGeAlD
Promethazine—Coordination abnormal—Epirubicin—ovarian cancer	0.000623	0.00345	CcSEcCtD
Promethazine—Leukopenia—Vinorelbine—ovarian cancer	0.000622	0.00344	CcSEcCtD
Promethazine—HRH1—testis—ovarian cancer	0.000618	0.00554	CbGeAlD
Promethazine—CALM2—lymph node—ovarian cancer	0.000617	0.00553	CbGeAlD
Promethazine—Palpitations—Vinorelbine—ovarian cancer	0.000614	0.0034	CcSEcCtD
Promethazine—CALM1—lymph node—ovarian cancer	0.000614	0.0055	CbGeAlD
Promethazine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000614	0.0034	CcSEcCtD
Promethazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.000613	0.00339	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—ovarian cancer	0.000608	0.00337	CcSEcCtD
Promethazine—Hypotension—Melphalan—ovarian cancer	0.000607	0.00336	CcSEcCtD
Promethazine—Dermatitis contact—Epirubicin—ovarian cancer	0.000604	0.00335	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—ovarian cancer	0.000602	0.00333	CcSEcCtD
Promethazine—Depression—Paclitaxel—ovarian cancer	0.000597	0.0033	CcSEcCtD
Promethazine—Dyspepsia—Topotecan—ovarian cancer	0.000584	0.00323	CcSEcCtD
Promethazine—CYP2D6—female reproductive system—ovarian cancer	0.000583	0.00522	CbGeAlD
Promethazine—HTR2A—vagina—ovarian cancer	0.000579	0.00518	CbGeAlD
Promethazine—Decreased appetite—Topotecan—ovarian cancer	0.000577	0.00319	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—ovarian cancer	0.000576	0.00319	CcSEcCtD
Promethazine—Aplastic anaemia—Epirubicin—ovarian cancer	0.000574	0.00318	CcSEcCtD
Promethazine—Fatigue—Topotecan—ovarian cancer	0.000572	0.00317	CcSEcCtD
Promethazine—Dyspepsia—Melphalan—ovarian cancer	0.000572	0.00316	CcSEcCtD
Promethazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000567	0.00314	CcSEcCtD
Promethazine—Constipation—Topotecan—ovarian cancer	0.000567	0.00314	CcSEcCtD
Promethazine—Pain—Topotecan—ovarian cancer	0.000567	0.00314	CcSEcCtD
Promethazine—Decreased appetite—Melphalan—ovarian cancer	0.000565	0.00312	CcSEcCtD
Promethazine—ABCB1—epithelium—ovarian cancer	0.000564	0.00505	CbGeAlD
Promethazine—Injection site reaction—Doxorubicin—ovarian cancer	0.000563	0.00311	CcSEcCtD
Promethazine—Fatigue—Melphalan—ovarian cancer	0.00056	0.0031	CcSEcCtD
Promethazine—ABCB1—uterine cervix—ovarian cancer	0.00056	0.00501	CbGeAlD
Promethazine—Dermatitis contact—Doxorubicin—ovarian cancer	0.000559	0.0031	CcSEcCtD
Promethazine—Coma—Epirubicin—ovarian cancer	0.000559	0.00309	CcSEcCtD
Promethazine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000556	0.00307	CcSEcCtD
Promethazine—Pain—Melphalan—ovarian cancer	0.000555	0.00307	CcSEcCtD
Promethazine—Tachycardia—Vinorelbine—ovarian cancer	0.000554	0.00307	CcSEcCtD
Promethazine—Bradycardia—Paclitaxel—ovarian cancer	0.000547	0.00303	CcSEcCtD
Promethazine—Feeling abnormal—Topotecan—ovarian cancer	0.000547	0.00303	CcSEcCtD
Promethazine—Asthenia—Chlorambucil—ovarian cancer	0.000535	0.00296	CcSEcCtD
Promethazine—ABCB1—decidua—ovarian cancer	0.000533	0.00477	CbGeAlD
Promethazine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000531	0.00294	CcSEcCtD
Promethazine—CYP2D6—female gonad—ovarian cancer	0.00053	0.00475	CbGeAlD
Promethazine—Hypotension—Vinorelbine—ovarian cancer	0.00053	0.00293	CcSEcCtD
Promethazine—Pruritus—Chlorambucil—ovarian cancer	0.000527	0.00292	CcSEcCtD
Promethazine—Coma—Doxorubicin—ovarian cancer	0.000517	0.00286	CcSEcCtD
Promethazine—HTR2A—testis—ovarian cancer	0.000516	0.00462	CbGeAlD
Promethazine—Phlebitis—Epirubicin—ovarian cancer	0.000515	0.00285	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—ovarian cancer	0.000513	0.00284	CcSEcCtD
Promethazine—Diarrhoea—Chlorambucil—ovarian cancer	0.00051	0.00282	CcSEcCtD
Promethazine—ABCB1—endometrium—ovarian cancer	0.000506	0.00453	CbGeAlD
Promethazine—Photosensitivity—Epirubicin—ovarian cancer	0.000506	0.0028	CcSEcCtD
Promethazine—Tinnitus—Paclitaxel—ovarian cancer	0.000501	0.00277	CcSEcCtD
Promethazine—Jaundice—Docetaxel—ovarian cancer	0.000494	0.00274	CcSEcCtD
Promethazine—Decreased appetite—Vinorelbine—ovarian cancer	0.000493	0.00273	CcSEcCtD
Promethazine—Fatigue—Vinorelbine—ovarian cancer	0.000489	0.00271	CcSEcCtD
Promethazine—Pain—Vinorelbine—ovarian cancer	0.000485	0.00269	CcSEcCtD
Promethazine—Constipation—Vinorelbine—ovarian cancer	0.000485	0.00269	CcSEcCtD
Promethazine—Arrhythmia—Paclitaxel—ovarian cancer	0.00048	0.00266	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—ovarian cancer	0.000477	0.00264	CcSEcCtD
Promethazine—Asthenia—Topotecan—ovarian cancer	0.000476	0.00263	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000475	0.00263	CcSEcCtD
Promethazine—Agranulocytosis—Docetaxel—ovarian cancer	0.000473	0.00262	CcSEcCtD
Promethazine—CYP2D6—testis—ovarian cancer	0.00047	0.00421	CbGeAlD
Promethazine—ABCB1—gonad—ovarian cancer	0.000469	0.0042	CbGeAlD
Promethazine—Pruritus—Topotecan—ovarian cancer	0.000469	0.0026	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—ovarian cancer	0.000468	0.00259	CcSEcCtD
Promethazine—Erythema—Paclitaxel—ovarian cancer	0.000468	0.00259	CcSEcCtD
Promethazine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000468	0.00259	CcSEcCtD
Promethazine—ABCB1—uterus—ovarian cancer	0.000466	0.00418	CbGeAlD
Promethazine—Asthenia—Melphalan—ovarian cancer	0.000466	0.00258	CcSEcCtD
Promethazine—Pruritus—Melphalan—ovarian cancer	0.00046	0.00254	CcSEcCtD
Promethazine—Tension—Paclitaxel—ovarian cancer	0.000459	0.00254	CcSEcCtD
Promethazine—Nervousness—Paclitaxel—ovarian cancer	0.000454	0.00251	CcSEcCtD
Promethazine—Diarrhoea—Topotecan—ovarian cancer	0.000454	0.00251	CcSEcCtD
Promethazine—Muscle spasms—Paclitaxel—ovarian cancer	0.00045	0.00249	CcSEcCtD
Promethazine—HRH1—lymph node—ovarian cancer	0.000448	0.00401	CbGeAlD
Promethazine—Diarrhoea—Melphalan—ovarian cancer	0.000444	0.00246	CcSEcCtD
Promethazine—Diplopia—Epirubicin—ovarian cancer	0.000444	0.00246	CcSEcCtD
Promethazine—Vision blurred—Paclitaxel—ovarian cancer	0.000441	0.00244	CcSEcCtD
Promethazine—Dizziness—Topotecan—ovarian cancer	0.000439	0.00243	CcSEcCtD
Promethazine—Tremor—Paclitaxel—ovarian cancer	0.000438	0.00242	CcSEcCtD
Promethazine—Agitation—Paclitaxel—ovarian cancer	0.00043	0.00238	CcSEcCtD
Promethazine—Syncope—Paclitaxel—ovarian cancer	0.000419	0.00232	CcSEcCtD
Promethazine—ABCB1—female reproductive system—ovarian cancer	0.000419	0.00375	CbGeAlD
Promethazine—Leukopenia—Paclitaxel—ovarian cancer	0.000419	0.00232	CcSEcCtD
Promethazine—Rash—Topotecan—ovarian cancer	0.000418	0.00231	CcSEcCtD
Promethazine—Dermatitis—Topotecan—ovarian cancer	0.000418	0.00231	CcSEcCtD
Promethazine—Headache—Topotecan—ovarian cancer	0.000416	0.0023	CcSEcCtD
Promethazine—Palpitations—Paclitaxel—ovarian cancer	0.000413	0.00229	CcSEcCtD
Promethazine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000411	0.00227	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—ovarian cancer	0.000411	0.00227	CcSEcCtD
Promethazine—Rash—Melphalan—ovarian cancer	0.00041	0.00227	CcSEcCtD
Promethazine—Dermatitis—Melphalan—ovarian cancer	0.000409	0.00226	CcSEcCtD
Promethazine—Asthenia—Vinorelbine—ovarian cancer	0.000407	0.00225	CcSEcCtD
Promethazine—Arrhythmia—Docetaxel—ovarian cancer	0.000407	0.00225	CcSEcCtD
Promethazine—Convulsion—Paclitaxel—ovarian cancer	0.000405	0.00224	CcSEcCtD
Promethazine—Pruritus—Vinorelbine—ovarian cancer	0.000401	0.00222	CcSEcCtD
Promethazine—Anxiety—Paclitaxel—ovarian cancer	0.000397	0.0022	CcSEcCtD
Promethazine—Erythema—Docetaxel—ovarian cancer	0.000396	0.00219	CcSEcCtD
Promethazine—ABCB1—bone marrow—ovarian cancer	0.000396	0.00354	CbGeAlD
Promethazine—Dry mouth—Paclitaxel—ovarian cancer	0.000389	0.00216	CcSEcCtD
Promethazine—Diarrhoea—Vinorelbine—ovarian cancer	0.000388	0.00215	CcSEcCtD
Promethazine—Confusional state—Paclitaxel—ovarian cancer	0.000385	0.00213	CcSEcCtD
Promethazine—Asthma—Epirubicin—ovarian cancer	0.000384	0.00212	CcSEcCtD
Promethazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000382	0.00211	CcSEcCtD
Promethazine—Oedema—Paclitaxel—ovarian cancer	0.000382	0.00211	CcSEcCtD
Promethazine—ABCB1—female gonad—ovarian cancer	0.000381	0.00342	CbGeAlD
Promethazine—Muscle spasms—Docetaxel—ovarian cancer	0.000381	0.00211	CcSEcCtD
Promethazine—ABCB1—vagina—ovarian cancer	0.000379	0.0034	CbGeAlD
Promethazine—Shock—Paclitaxel—ovarian cancer	0.000376	0.00208	CcSEcCtD
Promethazine—Dizziness—Vinorelbine—ovarian cancer	0.000375	0.00208	CcSEcCtD
Promethazine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000374	0.00207	CcSEcCtD
Promethazine—Tachycardia—Paclitaxel—ovarian cancer	0.000373	0.00206	CcSEcCtD
Promethazine—Rash—Vinorelbine—ovarian cancer	0.000358	0.00198	CcSEcCtD
Promethazine—Dermatitis—Vinorelbine—ovarian cancer	0.000357	0.00198	CcSEcCtD
Promethazine—Hypotension—Paclitaxel—ovarian cancer	0.000357	0.00197	CcSEcCtD
Promethazine—Headache—Vinorelbine—ovarian cancer	0.000355	0.00197	CcSEcCtD
Promethazine—Syncope—Docetaxel—ovarian cancer	0.000355	0.00197	CcSEcCtD
Promethazine—Asthma—Doxorubicin—ovarian cancer	0.000355	0.00196	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—ovarian cancer	0.000355	0.00196	CcSEcCtD
Promethazine—Palpitations—Docetaxel—ovarian cancer	0.00035	0.00194	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00035	0.00194	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—ovarian cancer	0.000348	0.00193	CcSEcCtD
Promethazine—Insomnia—Paclitaxel—ovarian cancer	0.000345	0.00191	CcSEcCtD
Promethazine—Convulsion—Docetaxel—ovarian cancer	0.000343	0.0019	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—ovarian cancer	0.000342	0.00189	CcSEcCtD
Promethazine—Somnolence—Paclitaxel—ovarian cancer	0.000339	0.00188	CcSEcCtD
Promethazine—ABCB1—testis—ovarian cancer	0.000338	0.00303	CbGeAlD
Promethazine—Dyspepsia—Paclitaxel—ovarian cancer	0.000336	0.00186	CcSEcCtD
Promethazine—Jaundice—Epirubicin—ovarian cancer	0.000333	0.00185	CcSEcCtD
Promethazine—Decreased appetite—Paclitaxel—ovarian cancer	0.000332	0.00184	CcSEcCtD
Promethazine—Dry mouth—Docetaxel—ovarian cancer	0.00033	0.00183	CcSEcCtD
Promethazine—Fatigue—Paclitaxel—ovarian cancer	0.000329	0.00182	CcSEcCtD
Promethazine—Constipation—Paclitaxel—ovarian cancer	0.000326	0.00181	CcSEcCtD
Promethazine—Pain—Paclitaxel—ovarian cancer	0.000326	0.00181	CcSEcCtD
Promethazine—Confusional state—Docetaxel—ovarian cancer	0.000326	0.00181	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000324	0.00179	CcSEcCtD
Promethazine—Oedema—Docetaxel—ovarian cancer	0.000324	0.00179	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000324	0.00179	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000319	0.00177	CcSEcCtD
Promethazine—Shock—Docetaxel—ovarian cancer	0.000318	0.00176	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000317	0.00175	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—ovarian cancer	0.000317	0.00175	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—ovarian cancer	0.000316	0.00175	CcSEcCtD
Promethazine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000315	0.00174	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—ovarian cancer	0.000313	0.00173	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—ovarian cancer	0.000309	0.00171	CcSEcCtD
Promethazine—Hypotension—Docetaxel—ovarian cancer	0.000302	0.00167	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000295	0.00164	CcSEcCtD
Promethazine—Insomnia—Docetaxel—ovarian cancer	0.000293	0.00162	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—ovarian cancer	0.000289	0.0016	CcSEcCtD
Promethazine—Somnolence—Docetaxel—ovarian cancer	0.000288	0.00159	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—ovarian cancer	0.000286	0.00158	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—ovarian cancer	0.000285	0.00158	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—ovarian cancer	0.000281	0.00156	CcSEcCtD
Promethazine—Fatigue—Docetaxel—ovarian cancer	0.000279	0.00154	CcSEcCtD
Promethazine—Constipation—Docetaxel—ovarian cancer	0.000277	0.00153	CcSEcCtD
Promethazine—Pain—Docetaxel—ovarian cancer	0.000277	0.00153	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—ovarian cancer	0.000274	0.00152	CcSEcCtD
Promethazine—Asthenia—Paclitaxel—ovarian cancer	0.000274	0.00152	CcSEcCtD
Promethazine—Pruritus—Paclitaxel—ovarian cancer	0.00027	0.00149	CcSEcCtD
Promethazine—Erythema—Epirubicin—ovarian cancer	0.000267	0.00148	CcSEcCtD
Promethazine—Feeling abnormal—Docetaxel—ovarian cancer	0.000267	0.00148	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—ovarian cancer	0.000265	0.00147	CcSEcCtD
Promethazine—Tension—Epirubicin—ovarian cancer	0.000262	0.00145	CcSEcCtD
Promethazine—Diarrhoea—Paclitaxel—ovarian cancer	0.000261	0.00145	CcSEcCtD
Promethazine—Nervousness—Epirubicin—ovarian cancer	0.00026	0.00144	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—ovarian cancer	0.000257	0.00142	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—ovarian cancer	0.000254	0.00141	CcSEcCtD
Promethazine—Dizziness—Paclitaxel—ovarian cancer	0.000252	0.0014	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—ovarian cancer	0.000252	0.00139	CcSEcCtD
Promethazine—Erythema—Doxorubicin—ovarian cancer	0.000247	0.00137	CcSEcCtD
Promethazine—Agitation—Epirubicin—ovarian cancer	0.000246	0.00136	CcSEcCtD
Promethazine—ABCB1—lymph node—ovarian cancer	0.000245	0.0022	CbGeAlD
Promethazine—Tension—Doxorubicin—ovarian cancer	0.000243	0.00134	CcSEcCtD
Promethazine—Rash—Paclitaxel—ovarian cancer	0.000241	0.00133	CcSEcCtD
Promethazine—Dermatitis—Paclitaxel—ovarian cancer	0.00024	0.00133	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—ovarian cancer	0.00024	0.00133	CcSEcCtD
Promethazine—Syncope—Epirubicin—ovarian cancer	0.00024	0.00133	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—ovarian cancer	0.000239	0.00132	CcSEcCtD
Promethazine—Headache—Paclitaxel—ovarian cancer	0.000239	0.00132	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000238	0.00132	CcSEcCtD
Promethazine—Palpitations—Epirubicin—ovarian cancer	0.000236	0.00131	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—ovarian cancer	0.000235	0.0013	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—ovarian cancer	0.000233	0.00129	CcSEcCtD
Promethazine—Asthenia—Docetaxel—ovarian cancer	0.000232	0.00128	CcSEcCtD
Promethazine—Convulsion—Epirubicin—ovarian cancer	0.000232	0.00128	CcSEcCtD
Promethazine—Pruritus—Docetaxel—ovarian cancer	0.000229	0.00127	CcSEcCtD
Promethazine—Agitation—Doxorubicin—ovarian cancer	0.000227	0.00126	CcSEcCtD
Promethazine—Anxiety—Epirubicin—ovarian cancer	0.000227	0.00126	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—ovarian cancer	0.000223	0.00123	CcSEcCtD
Promethazine—Syncope—Doxorubicin—ovarian cancer	0.000222	0.00123	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—ovarian cancer	0.000221	0.00123	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—ovarian cancer	0.000221	0.00123	CcSEcCtD
Promethazine—Confusional state—Epirubicin—ovarian cancer	0.00022	0.00122	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—ovarian cancer	0.000219	0.00121	CcSEcCtD
Promethazine—Oedema—Epirubicin—ovarian cancer	0.000218	0.00121	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000218	0.00121	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000217	0.0012	CcSEcCtD
Promethazine—Shock—Epirubicin—ovarian cancer	0.000215	0.00119	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—ovarian cancer	0.000214	0.00119	CcSEcCtD
Promethazine—Dizziness—Docetaxel—ovarian cancer	0.000214	0.00118	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000214	0.00118	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—ovarian cancer	0.000213	0.00118	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—ovarian cancer	0.00021	0.00116	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—ovarian cancer	0.000206	0.00114	CcSEcCtD
Promethazine—Rash—Docetaxel—ovarian cancer	0.000204	0.00113	CcSEcCtD
Promethazine—Hypotension—Epirubicin—ovarian cancer	0.000204	0.00113	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—ovarian cancer	0.000204	0.00113	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—ovarian cancer	0.000204	0.00113	CcSEcCtD
Promethazine—Headache—Docetaxel—ovarian cancer	0.000203	0.00112	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000202	0.00112	CcSEcCtD
Promethazine—Oedema—Doxorubicin—ovarian cancer	0.000202	0.00112	CcSEcCtD
Promethazine—Shock—Doxorubicin—ovarian cancer	0.000199	0.0011	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000198	0.00109	CcSEcCtD
Promethazine—Insomnia—Epirubicin—ovarian cancer	0.000197	0.00109	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—ovarian cancer	0.000197	0.00109	CcSEcCtD
Promethazine—Somnolence—Epirubicin—ovarian cancer	0.000194	0.00107	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—ovarian cancer	0.000192	0.00106	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—ovarian cancer	0.00019	0.00105	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—ovarian cancer	0.000189	0.00104	CcSEcCtD
Promethazine—Fatigue—Epirubicin—ovarian cancer	0.000188	0.00104	CcSEcCtD
Promethazine—Pain—Epirubicin—ovarian cancer	0.000187	0.00103	CcSEcCtD
Promethazine—Constipation—Epirubicin—ovarian cancer	0.000187	0.00103	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—ovarian cancer	0.000183	0.00101	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—ovarian cancer	0.00018	0.000995	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—ovarian cancer	0.000179	0.000993	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—ovarian cancer	0.000178	0.000984	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000176	0.000971	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—ovarian cancer	0.000174	0.000963	CcSEcCtD
Promethazine—Constipation—Doxorubicin—ovarian cancer	0.000173	0.000956	CcSEcCtD
Promethazine—Pain—Doxorubicin—ovarian cancer	0.000173	0.000956	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000166	0.000921	CcSEcCtD
Promethazine—Asthenia—Epirubicin—ovarian cancer	0.000157	0.000866	CcSEcCtD
Promethazine—Pruritus—Epirubicin—ovarian cancer	0.000154	0.000854	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—ovarian cancer	0.000149	0.000826	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—ovarian cancer	0.000145	0.000802	CcSEcCtD
Promethazine—Dizziness—Epirubicin—ovarian cancer	0.000144	0.000799	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—ovarian cancer	0.000143	0.000791	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—ovarian cancer	0.000138	0.000765	CcSEcCtD
Promethazine—Rash—Epirubicin—ovarian cancer	0.000138	0.000761	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—ovarian cancer	0.000137	0.000761	CcSEcCtD
Promethazine—Headache—Epirubicin—ovarian cancer	0.000137	0.000757	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—ovarian cancer	0.000134	0.000739	CcSEcCtD
Promethazine—Rash—Doxorubicin—ovarian cancer	0.000127	0.000705	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—ovarian cancer	0.000127	0.000704	CcSEcCtD
Promethazine—Headache—Doxorubicin—ovarian cancer	0.000126	0.0007	CcSEcCtD
Promethazine—Diltiazem—ABCB1—ovarian cancer	0.000113	0.127	CrCbGaD
Promethazine—Triflupromazine—ABCB1—ovarian cancer	0.000101	0.113	CrCbGaD
Promethazine—Carbamazepine—ABCB1—ovarian cancer	8.43e-05	0.0942	CrCbGaD
Promethazine—Clomipramine—ABCB1—ovarian cancer	7.11e-05	0.0794	CrCbGaD
Promethazine—Chlorprothixene—ABCB1—ovarian cancer	7.08e-05	0.0791	CrCbGaD
Promethazine—Trimipramine—ABCB1—ovarian cancer	6.54e-05	0.0731	CrCbGaD
Promethazine—Doxepin—ABCB1—ovarian cancer	6.23e-05	0.0696	CrCbGaD
Promethazine—Trifluoperazine—ABCB1—ovarian cancer	6.21e-05	0.0694	CrCbGaD
Promethazine—Methadone—ABCB1—ovarian cancer	6.2e-05	0.0693	CrCbGaD
Promethazine—Desipramine—ABCB1—ovarian cancer	5.72e-05	0.0639	CrCbGaD
Promethazine—Chlorpromazine—ABCB1—ovarian cancer	4.87e-05	0.0545	CrCbGaD
Promethazine—Imipramine—ABCB1—ovarian cancer	4.85e-05	0.0542	CrCbGaD
Promethazine—Amitriptyline—ABCB1—ovarian cancer	4.82e-05	0.0539	CrCbGaD
Promethazine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	7.31e-06	4.16e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	7.3e-06	4.15e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	7.29e-06	4.15e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	7.27e-06	4.14e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	7.25e-06	4.12e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—ovarian cancer	7.22e-06	4.11e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK1—ovarian cancer	7.22e-06	4.11e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—ovarian cancer	7.22e-06	4.11e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	7.22e-06	4.11e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	7.2e-06	4.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MTOR—ovarian cancer	7.2e-06	4.1e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—ovarian cancer	7.2e-06	4.1e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—ovarian cancer	7.2e-06	4.1e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	7.19e-06	4.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	7.19e-06	4.09e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	7.18e-06	4.08e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	7.16e-06	4.07e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—ovarian cancer	7.15e-06	4.07e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—ovarian cancer	7.15e-06	4.07e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—ovarian cancer	7.14e-06	4.06e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—ovarian cancer	7.14e-06	4.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	7.06e-06	4.02e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	7.06e-06	4.02e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	7.05e-06	4.01e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	6.99e-06	3.98e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK1—ovarian cancer	6.99e-06	3.98e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK1—ovarian cancer	6.99e-06	3.98e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—ovarian cancer	6.98e-06	3.97e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—ovarian cancer	6.98e-06	3.97e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	6.96e-06	3.96e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MTOR—ovarian cancer	6.96e-06	3.96e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MTOR—ovarian cancer	6.96e-06	3.96e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	6.96e-06	3.96e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	6.92e-06	3.94e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	6.91e-06	3.93e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—ovarian cancer	6.91e-06	3.93e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	6.88e-06	3.91e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	6.87e-06	3.91e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—ovarian cancer	6.82e-06	3.88e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—ovarian cancer	6.81e-06	3.88e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—ovarian cancer	6.79e-06	3.87e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—ovarian cancer	6.79e-06	3.86e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	6.77e-06	3.85e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	6.76e-06	3.84e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	6.75e-06	3.84e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	6.73e-06	3.83e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	6.71e-06	3.82e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	6.7e-06	3.81e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	6.69e-06	3.81e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	6.69e-06	3.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—ovarian cancer	6.69e-06	3.81e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	6.69e-06	3.8e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	6.67e-06	3.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	6.67e-06	3.79e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	6.63e-06	3.77e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	6.63e-06	3.77e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—ovarian cancer	6.62e-06	3.77e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—ovarian cancer	6.61e-06	3.76e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—ovarian cancer	6.61e-06	3.76e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—ovarian cancer	6.6e-06	3.75e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—ovarian cancer	6.6e-06	3.75e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	6.58e-06	3.74e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—ovarian cancer	6.58e-06	3.74e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—ovarian cancer	6.57e-06	3.74e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—ovarian cancer	6.57e-06	3.74e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	6.56e-06	3.74e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	6.56e-06	3.73e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	6.55e-06	3.73e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	6.54e-06	3.72e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	6.54e-06	3.72e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CB—ovarian cancer	6.52e-06	3.71e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	6.51e-06	3.7e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—ovarian cancer	6.45e-06	3.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—ovarian cancer	6.41e-06	3.64e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—ovarian cancer	6.41e-06	3.64e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	6.4e-06	3.64e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—ovarian cancer	6.4e-06	3.64e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—ovarian cancer	6.4e-06	3.64e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	6.39e-06	3.64e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	6.38e-06	3.63e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	6.37e-06	3.63e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	6.37e-06	3.62e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—ovarian cancer	6.36e-06	3.62e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—ovarian cancer	6.36e-06	3.62e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	6.35e-06	3.61e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—ovarian cancer	6.33e-06	3.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	6.29e-06	3.58e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—ovarian cancer	6.28e-06	3.57e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	6.27e-06	3.57e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—ovarian cancer	6.27e-06	3.57e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—ovarian cancer	6.27e-06	3.57e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—ovarian cancer	6.26e-06	3.56e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—ovarian cancer	6.23e-06	3.55e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—ovarian cancer	6.23e-06	3.55e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	6.23e-06	3.54e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—ovarian cancer	6.22e-06	3.54e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—ovarian cancer	6.21e-06	3.54e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—ovarian cancer	6.19e-06	3.52e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	6.19e-06	3.52e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	6.19e-06	3.52e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—ovarian cancer	6.17e-06	3.51e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	6.17e-06	3.51e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	6.17e-06	3.51e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	6.15e-06	3.5e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—ovarian cancer	6.11e-06	3.48e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	6.1e-06	3.47e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	6.1e-06	3.47e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	6.1e-06	3.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	6.09e-06	3.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	6.09e-06	3.47e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	6.08e-06	3.46e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	6.08e-06	3.46e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—ovarian cancer	6.07e-06	3.46e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—ovarian cancer	6.07e-06	3.46e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	6.07e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—ovarian cancer	6.06e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—ovarian cancer	6.06e-06	3.45e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	6.06e-06	3.45e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	6.06e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—ovarian cancer	6.05e-06	3.44e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—ovarian cancer	6.05e-06	3.44e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	6.04e-06	3.44e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	6.04e-06	3.44e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—ovarian cancer	6.02e-06	3.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—ovarian cancer	6.02e-06	3.42e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—ovarian cancer	6.01e-06	3.42e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	5.98e-06	3.4e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	5.98e-06	3.4e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	5.97e-06	3.39e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	5.96e-06	3.39e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	5.87e-06	3.34e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	5.87e-06	3.34e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	5.85e-06	3.33e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—ovarian cancer	5.81e-06	3.31e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—ovarian cancer	5.81e-06	3.31e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—ovarian cancer	5.8e-06	3.3e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	5.75e-06	3.27e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	5.74e-06	3.27e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	5.72e-06	3.26e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	5.71e-06	3.25e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	5.65e-06	3.22e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—ovarian cancer	5.64e-06	3.21e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	5.63e-06	3.21e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	5.62e-06	3.2e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—ovarian cancer	5.61e-06	3.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—ovarian cancer	5.61e-06	3.19e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—ovarian cancer	5.56e-06	3.17e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—ovarian cancer	5.55e-06	3.16e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—ovarian cancer	5.55e-06	3.16e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—ovarian cancer	5.55e-06	3.16e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	5.44e-06	3.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	5.44e-06	3.09e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	5.39e-06	3.07e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—ovarian cancer	5.38e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—ovarian cancer	5.38e-06	3.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	5.37e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—ovarian cancer	5.37e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—ovarian cancer	5.37e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—ovarian cancer	5.37e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—ovarian cancer	5.37e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—ovarian cancer	5.36e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—ovarian cancer	5.36e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	5.32e-06	3.02e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—ovarian cancer	5.31e-06	3.02e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	5.29e-06	3.01e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	5.28e-06	3e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.27e-06	3e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	5.26e-06	2.99e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—ovarian cancer	5.25e-06	2.99e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	5.24e-06	2.98e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—ovarian cancer	5.2e-06	2.96e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	5.19e-06	2.95e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	5.18e-06	2.95e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—ovarian cancer	5.17e-06	2.94e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	5.14e-06	2.93e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	5.14e-06	2.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—ovarian cancer	5.12e-06	2.91e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—ovarian cancer	5.12e-06	2.91e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	5.11e-06	2.91e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—ovarian cancer	5.1e-06	2.9e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—ovarian cancer	5.09e-06	2.89e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—ovarian cancer	5.08e-06	2.89e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—ovarian cancer	5.08e-06	2.89e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—ovarian cancer	5.07e-06	2.89e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	5.06e-06	2.88e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—ovarian cancer	5.06e-06	2.88e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—ovarian cancer	5.02e-06	2.86e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	5.01e-06	2.85e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—ovarian cancer	5e-06	2.85e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—ovarian cancer	5e-06	2.85e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	4.97e-06	2.83e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—ovarian cancer	4.95e-06	2.82e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—ovarian cancer	4.95e-06	2.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	4.89e-06	2.78e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	4.89e-06	2.78e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—ovarian cancer	4.89e-06	2.78e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—ovarian cancer	4.89e-06	2.78e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	4.89e-06	2.78e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	4.88e-06	2.78e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	4.87e-06	2.77e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	4.85e-06	2.76e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	4.8e-06	2.73e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	4.79e-06	2.73e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—ovarian cancer	4.78e-06	2.72e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—ovarian cancer	4.76e-06	2.71e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	4.68e-06	2.66e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—ovarian cancer	4.67e-06	2.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—ovarian cancer	4.66e-06	2.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—ovarian cancer	4.64e-06	2.64e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—ovarian cancer	4.62e-06	2.63e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—ovarian cancer	4.62e-06	2.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—ovarian cancer	4.6e-06	2.62e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	4.58e-06	2.61e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—ovarian cancer	4.41e-06	2.51e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	4.39e-06	2.5e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	4.39e-06	2.5e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	4.32e-06	2.46e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	4.31e-06	2.45e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	4.3e-06	2.44e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—ovarian cancer	4.29e-06	2.44e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	4.28e-06	2.44e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—ovarian cancer	4.25e-06	2.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	4.25e-06	2.42e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	4.25e-06	2.42e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	4.24e-06	2.41e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	4.23e-06	2.41e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—ovarian cancer	4.15e-06	2.36e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—ovarian cancer	4.15e-06	2.36e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—ovarian cancer	4.11e-06	2.34e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—ovarian cancer	4.11e-06	2.34e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—ovarian cancer	4.06e-06	2.31e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.98e-06	2.26e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—ovarian cancer	3.93e-06	2.24e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—ovarian cancer	3.93e-06	2.24e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—ovarian cancer	3.89e-06	2.21e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—ovarian cancer	3.76e-06	2.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—ovarian cancer	3.76e-06	2.14e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.75e-06	2.13e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.72e-06	2.11e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—ovarian cancer	3.59e-06	2.04e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—ovarian cancer	3.47e-06	1.97e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—ovarian cancer	3.47e-06	1.97e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—ovarian cancer	3.25e-06	1.85e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.06e-06	1.74e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.04e-06	1.73e-05	CbGpPWpGaD
